ÂÜÀòÂÒÂ×

John Hayslip is a seasoned medical professional with extensive experience in oncology and clinical development. Currently serving as Chief Medical Officer at Verastem Oncology and I-Mab Biopharma, John has also held the position of VP, Clinical Development at Nektar Therapeutics. Previous roles include Executive Medical Director, Group Medical Director, and Medical Director at AbbVie, as well as Interim Division Chief for Hematology and Bone Marrow Transplant at University of Kentucky HealthCare. John Hayslip holds a Master of Science in Clinical Research from the Medical University of South Carolina and a medical degree from Northeast Ohio Medical University.